Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients. - Wikidata - awgldk - TriplyDB

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

http://www.wikidata.org/entity/Q34405353

about

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients Genome-wide estimate of the heritability of Multiple System Atrophy Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.ReNE: a cytoscape plugin for regulatory network enhancement.Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes.Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.Blood transcriptomics of drug-naïve sporadic Parkinson's disease patients.Splicing: is there an alternative contribution to Parkinson's disease?Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.Specific splice variants are associated with Parkinson's disease.Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease.Identification of key genes and pathways in Parkinson's disease through integrated analysis.Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.Hepatocyte nuclear factor-4 alpha in noise-induced cochlear neuropathy.Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease.Metaanalysis of flawed expression profiling data leading to erroneous Parkinson's biomarker identification Reply to Toker and Pavlidis: Blood biomarkers for Parkinson's disease.A review of genome-wide transcriptomics studies in Parkinson's disease.Computational systems biology approaches for Parkinson's disease.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.Analysis of blood-based gene expression in idiopathic Parkinson disease.The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.A network approach to diagnostic biomarkers in progressive supranuclear palsy.The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson's Disease in the Hungarian Population.Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.

P2860

Q28550937-D32E6634-D924-44A1-B190-0CB0F72DA769 Q30693139-21B49BB1-C9AF-4BCB-95C7-188EA76DD4E0 Q34287243-28BDAEB3-F46A-4815-B985-D392B09DFFCE Q34776355-739E7E1E-FF9A-47AA-9176-AB96EC2E9DF9 Q35078279-88BA3836-9287-4276-B6D1-97FAE2F7FA9D Q35129144-A77C9FE4-052C-4DEF-873C-E7C6E4F178A2 Q35824982-1BDE0266-C181-4558-AE60-CB28F04DBC8E Q36069844-6C10C059-7A20-429C-B4D0-B33CA2EB8AF8 Q36410154-50F5F6D8-F819-4AA5-BFB9-AB0906709537 Q37266082-587B29A9-36ED-4736-B078-770BE6DB7AE1 Q37729558-2E19FC19-40DC-4FC1-A5E4-B3820A7FD45A Q38430423-E7E7261B-C9CE-4BF1-880D-50972F2DC8A4 Q38725286-6D3CF26F-F0FB-4CDB-82AC-BD7C7F743724 Q38876217-4C3ACB9D-AA1D-4875-9E32-5B1D1CA16810 Q41215282-AE08B0FF-9C07-46A8-B543-968F2EFE13B0 Q42356555-D67C291E-FA9A-4C6E-92F8-74B3C7B69EC0 Q42356662-6F83084D-F881-4A4A-BA17-BC5132C831A2 Q42778276-6282D6EA-52C6-483F-8F00-E6F33CB757A2 Q45943481-613424E6-0556-4870-A6F7-67B751E03137 Q47338262-8939BCBA-AE5C-4EE8-B09B-C26BF7328581 Q47943502-3278FB3A-AC09-40B1-A6F3-D58D3DCFD77E Q47976347-283F204E-CF31-420B-99C3-5DFE51A5F0C0 Q48091480-D99D5F27-E3C5-4232-B592-448CE127D007 Q52322083-BEEA82F7-492B-46DA-958C-DA89B957D36E Q54426622-96D4FD6B-E1D4-4511-B364-58AE354767CE Q55161431-A1273E43-2522-4E0B-9009-5765C5831251 Q55257291-561E715E-A5CD-449F-87F3-0713E650A689

P2860

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

http://www.wikidata.org/entity/Q34405353

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@ast

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@en

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@nl

type

label

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@ast

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@en

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@nl

prefLabel

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@ast

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@en

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@nl

P1433

Q34405353-173A62AB-8FA1-4510-8D77-E9BA5272CEA6

P1476

Q34405353-167FFE1D-B7CD-4CB2-B455-8109287A65AA

P2093

Q34405353-27E1FDD5-E808-47E6-BF56-7BF694E53E93

Q34405353-510F4158-BA1C-4938-ABA5-556A75BB634A

Q34405353-8184D6CC-A8EC-4C95-A28D-42EC3DD9210F

Q34405353-BDF0A4CC-F143-4F55-846F-C5D61B786FAA

Q34405353-ED07CF61-1E68-46AE-B47B-994674CCCCFA

P2860

Q34405353-0AA40A19-DDFA-4A66-A476-CAC4A426EABD

Q34405353-0CB5A115-AF43-41C6-9E16-50B72D00CE54

Q34405353-0D30C1C3-E32D-4F3A-A9F2-D8AA9BE863CC

Q34405353-13F925A6-D942-4A4E-B851-3B304BEAB4A4

Q34405353-1532E2A1-62EA-41DA-B1F5-D5571F321C89

Q34405353-154229EC-D7E4-4475-8391-835028322197

Q34405353-15D7CB37-22BB-4D6E-B888-0BE96881157A

Q34405353-1CC21176-F8F0-412C-800E-6DA550C92D18

Q34405353-1CDA2158-193D-4092-A2CD-64E3D54CC069

Q34405353-22070B3B-8FF4-48BC-BBA1-74ED5699E66C

P304

Q34405353-521BAE33-11DB-4F38-A2E8-A7840972D977

P31

Q34405353-2E8884BE-4965-4F38-8B94-8272C36C45E2

P356

Q34405353-F88FC087-1606-4695-8760-27251BF85559

P407

Q34405353-3AF57F0F-B989-42A9-80D0-49C1F40A5B61

P433

Q34405353-DCD0F6BB-1F04-4018-A6B9-B7B6732C3663

P478

Q34405353-043D0703-FC73-4902-BF8D-EEA5967A2A47

P577

Q34405353-B70B417E-0936-4DBF-BF8E-7D8CA07C0089

P5875

Q34405353-EA52A277-F867-429B-B6D3-B57F1FE7BB78

P698

Q34405353-892CC8FB-CD76-486D-9D68-EA7492B8DE89

P921

Q34405353-38B38852-16C1-43A7-9919-DE1008ED2F54

P932

Q34405353-56E202C7-96F5-4343-BDDE-73AE61AA5BD5

P356

JOURNAL.PONE.0043595

P1433

P1476

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

@en

P2093

Alexey A Leontovich

http://www.w3.org/2001/XMLSchema#string

Arthur Watts

http://www.w3.org/2001/XMLSchema#string

Bernard M Ravina

http://www.w3.org/2001/XMLSchema#string

Jose A Santiago

http://www.w3.org/2001/XMLSchema#string

Judith A Potashkin

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular markers of early Parkinson's disease based on gene expression in blood

The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway.

Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1

DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly

Second consensus statement on the diagnosis of multiple system atrophy

P304

e43595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0043595

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230805268

http://www.w3.org/2001/XMLSchema#string

P698

22952715

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3428307

http://www.w3.org/2001/XMLSchema#string